2013-12-18 08:00:00 CET

2013-12-18 08:01:06 CET


REGULATED INFORMATION

Islandic
Össur hf. - Fjárhagsdagatal

Ossur Hf : Össur Reporting Calendar 2014


Announcement from Össur hf. No:26/2013
Reykjavik, 18 December 2013


Össur Reporting Calendar 2014

Following are the expected dates for publication of financial results for 2014:

First Quarter - 29 April 2014
Second Quarter - 24 July 2014
Third Quarter - 23 October 2014
Fourth Quarter and Annual Report - 5 February 2015
Annual General Meeting - 12 March 2015


Össur press releases by e-mail


If  you wish to  receive Össur press  releases by e-mail  please register at the
following web-site: http://www.ossur.com/investormailings.

About Össur
Össur  (NASDAQ OMX: OSSR)  is a global  leader in non-invasive orthopaedics that
help  people  live  a  life  without  limitations.  Its  business  is focused on
improving  people's  mobility  through  the  delivery of innovative technologies
within the fields of braces, supports, prosthetic limbs and compression therapy.
A  recognized "Technology Pioneer", Össur  invests significantly in research and
product  development; its  award-winning designs  ensuring a consistently strong
position  in the  market. Successful  patient and  clinical outcomes are further
empowered via Össur's educational programs and business solutions. Headquartered
in  Iceland, Össur has major  operations in the Americas,  Europe and Asia, with
additional distributors worldwide. www.ossur.com

Forward-Looking Statements
This press release includes "forward-looking statements" which involve risks and
uncertainties that could cause actual results to differ materially from results
expressed or implied by these statements. Össur hf. undertakes no obligation and
does not intend to update these forward-looking statements to reflect events or
circumstances occurring after this press release. You are cautioned not to place
undue reliance on these forward-looking statements, which speak only as of the
date of this press release. All forward-looking statements are qualified in
their entirety by this cautionary statement.

[HUG#1750707]